Tag: stroke
1. Partner death was associated with both ischemic stroke and intracerebral hemorrhage in the subsequent five years, though absolute risk differences were small.
2. Risk of intracerebral hemorrhage was particularly elevated within the first 30 days following partner death.
Evidence Rating Level: 2 (Good)
Stress can have a negative impact on various...
Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers
1. Patients with severe COVID-19 demonstrated a unique diaphragm myopathic phenotype compared to non-COVID-19 ICU patients.
2. It is unclear whether or not myopathy is a direct result of COVID-19.
Evidence Rating Level: 2 (Good)
Severe acute respiratory...
1. Microbleeds increase risk of intracerebral hemorrhage, ischemic stroke, recurrent stroke, and mortality.
2. Microbleeds do not appear to influence the effects of rivaroxaban treatment.
Evidence Rating Level: 2 (Good)
Cerebral microbleeds are known to be associated with intracerebral hemorrhage and recurrent. Questions have been raised related to antithrombitic treatment for those...
1. Microbleeds increase risk of intracerebral hemorrhage, ischemic stroke, recurrent stroke, and mortality.
2. Microbleeds do not appear to influence the effects of rivaroxaban treatment.
Evidence Rating Level: 2 (Good)
Cerebral microbleeds are known to be associated with intracerebral hemorrhage and recurrent. Questions have been raised related to antithrombitic treatment for those...
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source
1. Microbleeds increase risk of intracerebral hemorrhage, ischemic stroke, recurrent stroke, and mortality.
2. Microbleeds do not appear to influence the effects of rivaroxaban treatment.
Evidence Rating Level: 2 (Good)
Cerebral microbleeds are known to be associated with intracerebral...
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular atrial fibrillation at risk of bleeding.
2. Edoxaban did not significantly increase the incidence of major bleeding compared to placebo.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Atrial fibrillation and age are...
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular atrial fibrillation at risk of bleeding.
2. Edoxaban did not significantly increase the incidence of major bleeding compared to placebo.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Atrial fibrillation and age are...
1. Low-field, portable MRI appears to be a feasible neuroimaging option for patients hospitalized in ICUs and unable to be transported for traditional MRI.
2. All cases of point-of-care MRI, except for one, were in agreement with radiologic findings from traditional MRI and CT.
Evidence Rating Level: 2 (Good)
Study Rundown: Magnetic...
1. Cardiovascular events were significantly lower with a novel post-stroke management program compared to current standard care.
2. Post-stroke patients reported significantly better health-related quality of life in with a novel post-stroke management program compared to those receiving standard of care.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Strokes, including transient ischemic...
1. In a large, national sample, approximately 37.1% of patients with stroke history had uncontrolled blood pressure.
2. Most patients on medication were taking angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, diuretics, or calcium channel blockers.
Evidence Rating Level: 2 (Good)
Stroke is ranked as a leading cause of mortality and disability in...